- Barron's Alibaba Stock Could Double Over Its Split Plan. There Are Even More Reasons to Like It.
- Barron's Polestar's Strategy Comes Into Focus With New Car. Think Porsche.
- AMC’s stock jumps, but Amazon unlikely to acquire theater chain, analyst says
- More than 155,000 tech-sector employees have lost their jobs since the start of 2023
- Barron's No, Amazon Shouldn’t Buy AMC—or Any Other Movie Theater Chain
- Barron's Bitcoin and Other Cryptos Bounce Back From Binance Wobble
- Barron's Rolls-Royce’s CEO Has a Turnaround Plan. The Stock Is Revving Up.
- This stock ETF keeps beating the S&P 500 by selecting for quality
- Seagate to increase the number of employees it lays off by 480
- Barron's Honeywell Takes Stake in Energy-Efficiency Start-Up
to be replaced
Teleflex Inc.
$
246.36
Close | Chg | Chg % |
---|---|---|
$246.36 | -0.66 | -0.27% |
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
TFX Overview
Key Data
- Open $246.14
- Day Range 245.58 - 248.84
- 52 Week Range 182.65 - 356.72
- Market Cap $11.6B
- Shares Outstanding 46.94M
- Public Float 46.81M
- Beta 0.94
- Rev. per Employee $180.07K
- P/E Ratio 32.10
- EPS $7.68
- Yield 0.55%
- Dividend $0.34
- Ex-Dividend Date Mar 2, 2023
- Short Interest 1.2M 03/15/23
- % of Float Shorted 2.57%
- Average Volume 342.1K
Performance
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Analyst Ratings
Recent News
Teleflex started at neutral with $220 stock price target at Mizuho
Teleflex started at hold with $370 stock price target at Truist
Teleflex downgraded to sector weight from overweight at KeyBanc Capital
Teleflex stock tumbles toward 8-month low, paces S&P 500 decliners
Shares of Teleflex Inc. tumbled 10.9% toward an 8-month low in afternoon trading Thursday, enough to pace the S&P 500 decliners, and to put them on track for the biggest one-day percentage selloff since March 2020. Telef...
Teleflex upgraded to overweight from sector weight at KeyBanc Capital
Teleflex stock price target raised to $425 from $400 at SVB Leerink
Teleflex recalls Babi.Plus water pressure relief manifold after reports of malfunction
Teleflex Inc. announced Monday a voluntary recall of its Babi.Plus water pressure relief manifold following a notice received from manufacturer GaleMed Corp. after reports that the bubble continuous positive airway pressu...
Teleflex says it's voluntarily recalling water pressure product from GaleMed
Teleflex downgraded to buy from strong buy at Needham
Teleflex stock price target raised to $348 from $320 at Raymond James
Teleflex to replace PG&E in the S&P 500 on Friday
Teleflex Inc. , a single-use medical devices company, will replace PG&E Corp. in the S&P 500 effective Jan. 18, the S&P Dow Jones Indices announced Tuesday. The changes come as PG&E indicated its intention to file for Ch...
7 Analysts Have This to Say About Teleflex
Teleflex: Dividend Insights
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Crispr Therapeutics AG (CRSP) and Pharvaris (PHVS)
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Down
Looking Into Teleflex's Return On Invested Capital
Analysts Are Bullish on Top Healthcare Stocks: Teleflex (TFX), Dynavax (DVAX)
Teleflex (TFX) Surpasses Q4 Earnings Estimates
Earnings Scheduled For February 23, 2023
Integra LifeSciences (IART) Tops Q4 Earnings and Revenue Estimates
Will Teleflex (TFX) Beat Estimates Again in Its Next Earnings Report?
Top 5 4th Quarter Trades of Riverstone Advisors, LLC
Top 5 4th Quarter Trades of Riverstone Advisors, LLC
Analyst Expectations for Teleflex's Future
The Zacks Analyst Blog Highlights Comcast, Aon, Trane Technologies, Huntington Bancshares and Teleflex
Top Analyst Reports for Comcast, Aon & Trane Technologies
Top 5 4th Quarter Trades of Bridge Creek Capital Management LLC
Top 5 4th Quarter Trades of Bridge Creek Capital Management LLC
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN) and Teleflex (TFX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regeneron (REGN – Research Report) and Teleflex (TFX – Research Report). Regeneron (REGN) In a report issued on January 13, B...
Here's Why You Should Hold on to Teleflex (TFX) Stock for Now
Teleflex (TFX) OEM Arm Grows, Supply Issue Persists
Needham Sticks to Their Buy Rating for Teleflex (TFX)
Needham analyst Michael Matson maintained a Buy rating on Teleflex (TFX - Research Report) today and set a price target of $291.00. The company's shares closed yesterday at $249.85.Matson covers the Healthcare sector, focu...
Where Teleflex Stands With Analysts
Teleflex Inc.
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.
Competitors
Name | Chg % | Market Cap |
---|---|---|
Johnson & Johnson | $399.24B | |
Medtronic PLC | $105.95B | |
Boston Scientific Corp. | $69.34B | |
Sonova Holding AG | CHF15.03B | |
Penumbra Inc. | $10.58B | |
ICU Medical Inc. | $3.77B | |
LivaNova PLC | $2.28B | |
Inari Medical Inc. | $3.32B | |
Medartis Holding AG | CHF823.83M | |
Boston Scientific Corp. 5.5% Pfd. Series A |